Management of Gridhrasi with Vatari Guggulu

Etiopathological study of Vata Kaphaja Gridhrasi And its Management with Vatari Guggulu

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/03/024025

Enrollment

Registered

2020-03-18

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G541- Lumbosacral plexus disorders

Interventions

Intervention1: Vatari Guggulu: Vatari Guggulu will be given in the patients of Vatakaphaja Gridhrasi 3 Tab of 500 mg each twice with lukewarm water before meal for 1 month Control Intervention1: NIL:

Eligibility

Inclusion criteria

Inclusion criteria: Patient having cardinal symptoms of Vata Kaphaja Gridhrasi like Ruka Toda Stambha Spandana Aruchi Tandra Gaurava along with positive SLR test Patients willing to participate in study

Exclusion criteria

Exclusion criteria: Age below 20 and above 60 years Patients suffer from any other systemic disorders Spinal deformity Spinal tumor Traumatic injury to spine congenital spine deformity

Design outcomes

Primary

Measure	Time frame
To study etiological factors of Vata Kaphaja Gridhrasi in present era dietetics life styleTimepoint: 1 month	—

Secondary

Measure	Time frame
To evaluate the efficacy of Vatari Guggulu in the management of Vata Kaphaja GridhrasiTimepoint: 1 month	—

Countries

India

Contacts

Public ContactDr Darshna Pandya

Institute for Post Graduate Teaching and Research in Ayurveda Gujarat Ayurved University Jamnagar

darshnapandya@rediffmail.com9099011095

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026